Actively Recruiting
Evaluating Probiotics for Constipation Relief in Adults Using a Randomized, Double-Blind, Placebo-Controlled Trial
Led by Wecare Probiotics Co., Ltd. · Updated on 2026-08-28
70
Participants Needed
1
Research Sites
11 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of probiotics on adults experiencing functional constipation. This randomized, double-blind, placebo-controlled trial aims to study changes in bowel habits and symptom severity, as well as impacts on inflammation, immune response, gut microbiome, neuroendocrine communication related to the gut-brain axis, and overall metabolism. The purpose is to understand the broader physiological effects of taking probiotics. Participants will be randomly assigned to receive either probiotics or a placebo once daily for 8 weeks. Study visits are scheduled at the start of the study Week 0, mid-point Week 4, and end Week 8 to monitor progress. Both groups will follow the same schedule and treatment frequency. Throughout the study, participants will be assessed for improvements in bowel function as the primary outcome after 8 weeks. Researchers will also evaluate various biological and physiological markers related to inflammation, immune modulation, and metabolic responses. Participants will need to attend scheduled visits and complete required assessments, with follow-up continuing through the 8-week treatment period.
CONDITIONS
Brief Title
Adults With Constipation
Research Team
Y
Ying Jin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here